Shock wave permeabilization with ribosome inactivating proteins: A new approach to tumor therapy

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5227-5232

  Delius, Michael ^a   Adams, Gerhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELONIN; RIBOSOME INACTIVATING PROTEIN; SAPORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DEVICE; EXTRACORPOREAL LITHOTRIPSY; FIBROSARCOMA; HELA CELL; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA L 1210; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; HIGH-ENERGY SHOCK WAVES; IMMUNOTOXINS; MICE; N-GLYCOSYL HYDROLASES; NEOPLASMS, EXPERIMENTAL; PLANT PROTEINS; RIBOSOMES; TUMOR CELLS, CULTURED;

EID: 0032748587     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Coleman, A. J., and Saunders, J. E. A survey of the acoustic output of commercial extracorporeal shock wave lithotripters. Ultrasound Med. Biol., 15: 213-227, 1989.
2. Chaussy, C., Brendel, W., and Schmiedt, E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet, ii: 1265-1268, 1980.
3. Delius, M. Medical applications and bioeffects of extracorporeal shock waves. Shock Waves, 4: 55-72, 1994.
4. Rompe, J. D., Hopf, C., Nafe, B., and Burger, R. Low-energy extracorporeal shock wave therapy for painful heel: a prospective controlled single-blind study. Arch. Orthop. Trauma Surg., 115: 75-79, 1996.
5. Haupt, G. Use of extracorporeal shock waves in the treatment of pseudarthrosis, tendinopathy and other orthopedic diseases. J. Urol., 158: 4-11, 1997.
6. Oosterhof, G., Smits, G., De Ruyter, A., Schalken, J., and Debruyne, F. Effects of high energy shock waves combined with biological response modifiers in different human kidney cancer xenografts. Ultrasound Med. Biol., 17: 391-399, 1991.
7. Weiss, N., Delius, M., Gambihler, S., Dirschedl, P., Goetz, A., and Brendel, W. Influence of the shock wave application mode on the growth of A-Mel 3 and SSK2 tumors in vivo. Ultrasound Med. Biol., 16: 595-605, 1990.
8. Gambihler, S., Delius, M., and Ellwart, J. W. Permeabilization of the plasma membrane of L1210 mouse leukemia cells using lithotripter shock waves. J. Membr. Biol., 141: 267-275, 1994.
9. Lauer, U., Bürgelt, E., Squire, Z., Messmer, K., Hofschneider, P. H., Gregor, M., and Delius, M. Shock wave permeabilization as new gene transfer method. Gene Ther., 4: 710-715, 1997.
10. Barbieri, L., Battelli, M. G., and Stirpe, F. Ribosome-inactivating proteins from plants. Biochim. Biophys. Acta, 1154: 237-282, 1993.
11. Frankel, A. E., FitzGerald, D., Siegal, C., and Press, O. W. Advances in immunotoxin biology and therapy: a summary of the Fourth International Symposium on Immunotoxins. Cancer Res., 56: 926-932, 1996.
12. Begg, A. C., Hofland, I., and Kummermehr, J. Tumor cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumors. Eur. J. Cancer, 27: 537-543, 1991.
13. Embleton, M. J. How to determine tumor immunogenicity. In: R. F. Kallman (ed.), Rodent Tumor Models in Experimental Cancer Therapy, pp. 19-22. New York: Pergamon Press, 1987.
14. Stirpe, F., Olsnes, S., and Pihl, A. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. J. Biol. Chem., 235; 6947-6953, 1980.
15. Stirpe, F., Gasperi-Campani, A., Barbieri, L., Falasca, A., Abbodanza, A., and Stevens, W. A. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree). Biochem. J., 216: 617-625, 1983.
16. Delius, M. Minimal static excess pressure minimizes the effect of extracorporeal shock waves on cells and reduces it on gallstones. Ultrasound. Med. Biol., 23: 611-617, 1997.
17. Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936-942, 1987.
18. Stirpe, F., and Barbieri, L. Ribosome-inactivating proteins up to date. FEBS Lett., 195: 1-8, 1986.
19. Goldmacher, V. S., Scott, C. F., Lambert, J. M., McIntyre, G. D., Blättler, W. A., Collinson, A. R., Stewart, J. K., Chong, L., Cook, S., Slayter, H. S., Beaumont, E., and Watkins, S. Cytotoxicity of gelonin and its conjugates with antibodies is determined by extent of their endocytosis. J. Cell Physiol., 141: 222-234, 1989.
20. Sandvig, K., and van Deurs, B. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev., 76: 949-966, 1996.
21. Gambihler, S., and Delius, M. In vitro interaction of lithotripter shock waves and cytotoxic drugs. Br. J. Cancer, 66: 69-73, 1992.
22. Wörle, K., Steinbach, P., and Hofstädter, F. The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells. Br. J. Cancer, 69: 58-65, 1994.
23. Philipp, A., Delius, M., Scheffcyk, C., Vogel, A., and Lauterbom, W. Interaction of lithotripter-generated shock waves with air bubbles. J. Acoust. Soc. Am., 93: 2496-2509, 1993.
24. Barbieri, L., Valbonesi, P., Bonora, E., Gorini, P., Bolognesi, A., and Stirpe, F. Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect of DNA, RNA and poly(A). Nucleic Acids Res., 25: 518-522, 1997.
25. Brigotti, M., Barbieri, L., Valbonesi, P., Stirpe, F., Montanaro, L., and Sperti, S. A rapid and sensitive method to measure the enzymatic activity of ribosome inactivating proteins. Nucleic Acids Res., 26: 4306-4307, 1998.
26. Eiklid, K., Olsnes, S., and Pihl, A. Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp. Cell Res., 126: 321-326, 1980.
27. Belehradek, M., Domenge, C., Luboinski, B., Orlowski, S., Belehradek, J., Jr., and Mir, L. M. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer (Phila.), 72: 3694-3700, 1993.
28. Dev, S. B., and Hofmann, G. A. Electrochemotherapy - a novel method of cancer treatment. Cancer Treat. Rev., 20: 105-115, 1994.
29. Mueller, M. Comparison of Dernier lithotripters. Measurement of shock wave fields and fragmentation effectiveness. Biomed. Technik, 35: 250-262, 1990.